Matches 1 - 50 out of 236 1 2 3 4 5 >
Match Document Document Title
7595327 Beta-sulfonamide hydroxamic acid inhibitors of tace/matrix metalloproteinase  
This invention provides compounds of Formula I, having the structure: that are useful in treating diseases or disorders mediated by TNF-α, such as arthritis (rheumatoid arthritis (RA),...
7569602 Furan derivatives as EP4 receptor antagonists  
A compound of formula (I): or a salt, solvate and chemically protected form thereof, wherein one of R 2 and R 5 is: (i) H or an optionally substituted C 1-4 alkyl group; or (ii) an...
7534894 Biphenyloxy-acids  
The present invention relates generally to substituted biphenyloxy acids (such as 4′-aryl-amido-biphenyl-4(3)-yloxy-acids and 4′-aryl-amidomethyl-biphenyl-4(3)-yloxy-acids) and methods of using...
7511073 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof  
One aspect of the present invention relates to amines. A second aspect of the present invention relates to the use of the amines as inhibitors of a mammalian anandamide transporter. The compounds...
7507817 Prostaglandin prodrugs  
Novel compounds, and therapeutic methods, compositions and medicament related thereto are disclosed herein.
7468446 Substituted heterocyclic compounds and uses thereof  
The present invention relates to substituted heterocyclic compounds and compositions comprising a substituted heterocyclic compound. The present invention also relates to methods for preventing or...
7468437 Phenyl pyrrolidine ether tachykinin receptor antagonists  
The present invention is directed to certain phenyl pyrrolidine ether compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular...
7442810 Method for the production of defined mixtures of THF, BDO and GBL by gas phase hydrogenation  
A process for variably preparing mixtures of optionally alkyl-substituted BDO, GBL and THF by two-stage hydrogenation in the gas phase of C 4 dicarboxylic acids and/or derivatives thereof, which...
7432284 Estrogen receptor modulators  
The present invention relates to compounds and derivatives thereof, their synthesis, and their use as estrogen receptor modulators. The compounds of the instant invention are ligands for estrogen...
7423061 Substitute thiophenes and uses thereof  
This invention relates to novel compounds having the structural formula (I) and to their pharmaceutical salts, compositions and methods of use. These novel compounds provide a treatment or...
7419943 Methanoazuenofurans and methanoazulenone compounds and uses of these compounds as fragrance materials  
The use of novel methanoazulenofuran and methanoazulenone compounds for use as fragrance chemicals, suitable for use incorporated in a wide variety of products such as perfumes, colognes and...
7417068 EP4 receptor antagonists  
A compound of formula (I): or a salt, solvate and chemically protected form thereof, wherein one of R 2 and R 5 is: (i) H or an optionally substituted C 1-4 alkyl group; or (ii)an...
7371777 Cyclic compound and PPAR agonist  
The present invention provides a novel compound having an excellent PPAR agonist action. More specifically, it provides a compound represented by the following formula, a salt thereof, an ester...
7351734 Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors  
The present invention relates to aminoindane derivatives having the formula I wherein X, Y, U, R 1-2 , R 13-16 and R are as defined in the claims, or an acid addition salt thereof. The compounds...
7351311 Method for purifying tetrahydrofuran by distillation  
Crude water-containing tetrahydrofuran is purified by passing the crude tetrahydrofuran through three distillation columns, withdrawing water from the bottom of the first column, recycling...
7345181 Process for preparing prostaglandin derivatives and starting materials for the same  
The present invention provides a process for preparing benzoprostacycline derivatives of formula (1), i.e. 5,6,7-trinor-4,8-inter-m-phenylene PGI2 derivatives, and vinyl tin compounds of formula...
7329634 3-Phenyl substituted 3-substituted-4ketolactams and ketolactones  
The invention relates to novel 3-phenyl-substituted, 3-substituted 4-ketolactams and -lactones of the formula (I) in which Q, W, X, Y, A, B and G are as defined in the disclosure, to...
7316851 Electroluminescent material, electroluminescent element and color conversion filter  
An electroluminescent element is disclosed, comprising an electroluminescent material and a fluorescent substance emitting light having an emission maximum at the wavelength different from that of...
7276573 Method for producing monoesters and diesters of polytetrahydrofuran and of tetrahydrofuran copolymers  
The present invention provides a process for preparing mono- or diesters of polytetrahydrofuran or of tetrahydrofuran copolymers by polymerizing tetrahydrofuran in the presence of at least one...
RE39794 Process for the simultaneous production of maleic anhydride and its hydrogenated derivatives  
A process is described for the co-production of maleic anhydride and at least one C 4 compound selected from butane-1,4-diol, γ-butyrolactone, and tetrahydrofuran in which maleic anhydride is...
7256203 Dicationic 2,5-diarylfuran aza-analogs as anti-protozoan agents  
A compound of Formula (I): wherein: X is selected from the group consisting of O, S, and NR 17 , where R 17 is hydrogen or lower alkyl; A and Y are CH, N, NR 17 , O, or S; C 1 and C 2 ...
7148318 Method for producing polytetrahydrofurane having a low color indices  
The invention provides a process for preparing polytetrahydrofuran, tetrahydrofuran copolymers, their monoesters or diesters and the monoesters or diesters of polytetrahydrofuran having a low color...
7144909 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands  
This invention relates to novel compounds which are thyroid receptor ligands, preferably antagonists, and to methods for using such compounds in the treatment of cardiac and metabolic disorders,...
7122561 Treatment of skin conditions  
The present invention provides piperine and analogues or derivatives thereof for the treatment of skin conditions treatable by stimulation of melanocyte proliferation, such as vitiligo, and also...
7109343 Metal catalysts and methods for making and using same  
Compounds having the formula: are disclosed. M 1 and M 2 are the same or different and are transition metal atoms or ions; Z 2 and Z 3 , independently, are the atoms necessary to complete a...
7105707 Process for preparing alkynyl-substituted aromatic and heterocyclic compounds  
Mono- and disubstituted aryl or heterocyclic acetylenes are produced by a process comprising reacting an aryl nitrile with an alkynylzinc compound, a bis-alkynylzinc compound, or an...
7091344 Infrared chromophores  
An infrared dye, characterized in that the dye comprises of Formulae 1 to 5
7081467 C2-disubstituted indan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals  
The present invention is directed C2-disubstituted indan-1-ones of the Formula I, physiologically acceptable salts, and physiologically functional derivatives thereof, and pharmaceutical...
7074944 Method for producing polytetrahydrofuran  
In a process for the single-stage preparation of polytetrahydrofuran and/or tetrahydrofuran copolymers having a mean molecular weight of from 650 to 5000 dalton by polymerization of tetrahydrofuran...
7064222 Processes for the preparation of 2-methylfuran and 2-methyltetrahydrofuran  
Processes are disclosed for the preparation of 2-methylfuran and 2-methyltetrahydrofuran. The continuous vapor-phase processes are commercially viable and efficient because they permit the...
7057055 Process for preparing a deuterated or tritiated compound  
A process for labeling organic compounds with deuterium and tritium is described using specific catalysts.
7049329 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof  
One aspect of the present invention relates to amines. A second aspect of the present invention relates to the use of the amines as inhibitors of a mammalian anandamide transporter. The compounds...
6930188 Stable hydrate of a muscarinic receptor antagonist  
A stable solid hydrate of a muscarinic receptor antagonist is useful in the treatment of irritable bowel syndrome, diverticular disease, oesophageal achalasia, chronic obstructive airways disease,...
6921831 Modified BiMo catalyst and process for use thereof  
Modified lead/bismuth/molybdate catalysts containing vanadium, copper, or gold have been prepared, and are selective to the corresponding furan compound from the gas phase oxidation of an...
6906196 Processes for the preparation of 1,5-diaryl-3-substituted-pyrazoles  
Provided are processes and chemical intermediates useful for preparing a compound of the formula I wherein X is selected from the group consisting of C 1 -C 6 trihalomethyl; C 1 -C 6 ...
6903132 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use  
Non-peptide GnRH agents capable of inhibiting the effect of gonadotropin-releasing hormone are described. Such compounds and their pharmaceutically acceptable salts, prodrugs, and active...
6894039 Selenophene anti-tumor agents  
Novel selenophene compounds useful as anti-tumor agents are described. Preferred compounds include compounds of formula I: wherein R 1 and R 2 are independently selected from the group...
6875784 Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives  
The present invention provides certain [3.1.0] bicyclic oxazolidinone derivatives of Formulea I and II, described herein, or pharmaceutically acceptable salts or prodrugs thereof that are...
6864225 Cyclic ketals, fragrance compositions containing the same and methods of using the same  
Compounds of the general formula (I) are described: wherein each of R 1 , R 2 , R 3 , R 4 , R 5 and R 6 independently represents a substituent selected from the group consisting of hydrogen,...
6844375 4-methylene-1,3-dioxolanes as cross-linking agents  
The invention relates to: 4-methylene-1,3-dioxolanes of the general formula (I) wherein R1 denotes hydrogen, C 5 -C 6 -cycloalkyl or C 1 -C 4 -alkyl; m and n, which may be the same or...
6812354 Process for preparing 3-methyltetrahydrofuran  
Disclosed is a process for the preparation of 3-methyltetrahydrofuran (MeTHF) from 3-(hydroxymethyl)tetrahydrofuran (HOMeTHF) or 3-formyltetrahydrofuran (FTHF) by contacting HOMeTHF or...
6764829 Nucleoside hydrolase and nucleoside phosphorylase detection kits, dipsticks and substrates  
The invention relates to a method of detecting and/or assaying nucleoside hydrolases or nucleoside phosphorylases using a chromogenic substrate. Preferred chromogenic substrates have formula (I)...
6762304 Metal catalysts and methods for making and using same  
Compounds having the formula: are disclosed. M 1 and M 2 are the same or different and are transition metal atoms or ions; Z 2 and Z 3 , independently, are the atoms necessary to complete a...
6762198 Dihetero-substituted metalloprotease inhibitors  
Disclosed are compounds which are inhibitors of metalloproteases and which are effective in treating conditions characterized by excess activity of these enzymes. In particular, the compounds have...
6730800 Method for the production of tetrahydrofuran  
Unsubstituted or alkyl-substituted THF is obtained by catalytic hydrogenation in the gas phase of C 4 -dicarboxylic acids and/or their derivatives using a catalyst comprising <80% by weight,...
6716987 Derivatives of benzofuran or benzodioxazole compounds  
An oxygen-containing heterocyclic compound represented by following Formula (I): wherein R 1 and R 2 independently represent hydrogen, lower alkyl, cyano, —(CH 2 ) n —E 1 —CO—G 1 ...
6683211 Phenyl-propargylether derivatives  
The invention relates to phenyl-propargylether derivatives of the general formula I including the optical isomers thereof and mixtures of such isomers, wherein R 1 is hydrogen, alkyl,...
6683107 Furans, benzofurans, and thiophenes useful in the treatment of insulin resistance and hyperglycemia  
This invention provides compounds of Formula I having the structure wherein R 1 and R 2 are each, independently, hydrogen, alkyl of 1-6 carbon atoms, halogen, perfluoroalkyl of 1-6 carbon...
6680391 Treatment of skin conditions  
The present invention provides piperine and analogues or derivatives thereof for the treatment of skin conditions treatable by stimulation of melanocyte proliferation, such as vitiligo, and also...
6660728 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists  
The present invention relates to thienyl substituted acylguanidine derivatives, such as compounds of formula (I) in which R 1 , R 2 , R 4 , R 6 , A, B and D have the meanings indicated in the...
Matches 1 - 50 out of 236 1 2 3 4 5 >